Christopher Canfield, DO

Nephrology in Philadelphia, PA

4453 Castor Ave, Suite B, Philadelphia, PA 19124 · Metropolitan Nephrology Associates, P.c.
NPI 1457855652 Accepts Medicare assignment 8 years since graduation Public record — not managed by the clinician

About Dr. Christopher Canfield

Dr. Christopher Canfield is a physician specializing in nephrology practicing in Philadelphia, PA, a graduate of Philadelphia College of Osteopathic Medicine (2018). Records list 2 practice addresses. Affiliated with Jefferson Health-Northeast, Temple University Hospital, Bma of Cambria and 1 more. Treated 237 Medicare patients in 2024.

SpecialtyNephrologyOther nephrology doctors in Philadelphia
CredentialsDO
EducationPhiladelphia College of Osteopathic Medicine, 2018CMS Doctors and Clinicians
GenderMale
NPI number1457855652National Provider Identifier (CMS NPPES), issued March 2018
MedicareEnrolled in Medicare; accepts Medicare assignment (the Medicare-approved amount as full payment)CMS Doctors and Clinicians

Where Dr. Christopher Canfield practices

Addresses from CMS Doctors and Clinicians (Medicare enrollment). Call before visiting: a clinician may not see patients at every listed address.

Dr. Christopher Canfield's specialties and state licenses

Specialty (NPPES)License
Nephrology PrimaryPA OS022674

As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.

Hospital affiliations of Dr. Christopher Canfield

  • Jefferson Health-NortheastHospital · Philadelphia, PA
  • Temple University HospitalHospital · Philadelphia, PA
  • Bma of CambriaDialysis facility · Philadelphia, PA
  • Fresenius Medical Care ParkviewDialysis facility · Philadelphia, PA

CMS Facility Affiliation data: facilities where the clinician bills Medicare.

Dr. Christopher Canfield's Medicare patients and services (2024)

237Medicare patients
731services billed
69average patient age
46%women

Most frequent services

ServiceTimesAvg. Medicare allowed
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes247$79.46
Dialysis services, 4 or more physician visits per month (20 years or older)141$355.58
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes59$131.89
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes37$119.33
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more28$131.53
Transitional care management services for problem of high complexity23$285.67
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more21$184.46
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's19$16.65

Common conditions among these patients

  • Chronic kidney disease75%
  • High cholesterol75%
  • High blood pressure75%
  • Diabetes67%
  • Ischemic heart disease62%
  • Heart failure58%

Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.

Dr. Christopher Canfield's Medicare quality score (MIPS 2024)

86.5/100final MIPS score
65.6quality
100promoting interoperability
40improvement activities
77.6cost

The Merit-based Incentive Payment System scores clinicians who bill Medicare. Reported as group. Source: CMS Care Compare, PY 2024 clinician public reporting.

Payments from drug and device companies to Dr. Christopher Canfield (2025)

$1,380.24 in 50 general payments reported in 2025.

TypePaymentsAmount
Food and beverage50$1,380.24

Paying companies: Novo Nordisk Inc ($225.72), NOVARTIS PHARMACEUTICALS CORPORATION ($208.98), Ardelyx, Inc. ($185.15), AKEBIA THERAPEUTICS INC ($87.15), Bayer HealthCare Pharmaceuticals Inc. ($81.67), Amgen Inc. ($80.53).

Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.

Questions about Dr. Christopher Canfield

What kind of clinician is Dr. Christopher Canfield?

Dr. Christopher Canfield is listed as a physician specializing in nephrology.

Where does Dr. Christopher Canfield practice?

Metropolitan Nephrology Associates, P.c. at 4453 Castor Ave, Suite B, Philadelphia, PA 19124, and 1 other address in the records.

What is the office phone number for Dr. Christopher Canfield?

The listed office number is (215) 744-2266. Call to confirm availability and whether new patients are accepted.

What is the NPI number of Dr. Christopher Canfield?

The National Provider Identifier is 1457855652.

Does Dr. Christopher Canfield accept Medicare?

Yes. CMS lists this clinician as accepting Medicare assignment. Confirm your plan with the office.

Which hospitals is Dr. Christopher Canfield affiliated with?

Jefferson Health-Northeast, Temple University Hospital, Bma of Cambria, Fresenius Medical Care Parkview.

Where did Dr. Christopher Canfield go to medical school?

Philadelphia College of Osteopathic Medicine, graduating in 2018.

Where this information comes from

CMS Doctors and CliniciansName, specialty, education, Medicare enrollment and practice addresses.Centers for Medicare & Medicaid Services, national downloadable file (2026)
NPPES NPI registryNPI, specialties (taxonomy) and state licenses.CMS National Plan and Provider Enumeration System; record updated 2023-11-14
Facility affiliationsHospitals and other facilities.CMS Doctors and Clinicians facility affiliation file; names from CMS Provider of Services
Medicare utilizationPatients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024
MIPSQuality payment program scores.CMS clinician public reporting, PY 2024
Open PaymentsPayments from drug and device companies.CMS Open Payments, program year 2025

Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.

0 clinics selected Compare